BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

464 related articles for article (PubMed ID: 30368246)

  • 1. Protective effects of mangafodipir against chemotherapy-induced ovarian damage in mice.
    Qin Y; Iwase A; Murase T; Bayasula ; Ishida C; Kato N; Nakamura T; Osuka S; Takikawa S; Goto M; Kotani T; Kikkawa F
    Reprod Biol Endocrinol; 2018 Oct; 16(1):106. PubMed ID: 30368246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improvement of the therapeutic index of anticancer drugs by the superoxide dismutase mimic mangafodipir.
    Alexandre J; Nicco C; Chéreau C; Laurent A; Weill B; Goldwasser F; Batteux F
    J Natl Cancer Inst; 2006 Feb; 98(4):236-44. PubMed ID: 16478742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The magnitude of gonadotoxicity of chemotherapy drugs on ovarian follicles and granulosa cells varies depending upon the category of the drugs and the type of granulosa cells.
    Yuksel A; Bildik G; Senbabaoglu F; Akin N; Arvas M; Unal F; Kilic Y; Karanfil I; Eryılmaz B; Yilmaz P; Ozkanbaş C; Taskiran C; Aksoy S; Guzel Y; Balaban B; Ince U; Iwase A; Urman B; Oktem O
    Hum Reprod; 2015 Dec; 30(12):2926-35. PubMed ID: 26466914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ceramide-1-phosphate has protective properties against cyclophosphamide-induced ovarian damage in a mice model of premature ovarian failure.
    Pascuali N; Scotti L; Di Pietro M; Oubiña G; Bas D; May M; Gómez Muñoz A; Cuasnicú PS; Cohen DJ; Tesone M; Abramovich D; Parborell F
    Hum Reprod; 2018 May; 33(5):844-859. PubMed ID: 29534229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C-Abl is not actıvated in DNA damage-induced and Tap63-mediated oocyte apoptosıs in human ovary.
    Bildik G; Acılan C; Sahin GN; Karahuseyinoglu S; Oktem O
    Cell Death Dis; 2018 Sep; 9(10):943. PubMed ID: 30237472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GnRH agonist leuprolide acetate does not confer any protection against ovarian damage induced by chemotherapy and radiation in vitro.
    Bildik G; Akin N; Senbabaoglu F; Sahin GN; Karahuseyinoglu S; Ince U; Taskiran C; Selek U; Yakin K; Guzel Y; Ayhan C; Alper E; Cetiner M; Balaban B; Mandel NM; Esen T; Iwase A; Urman B; Oktem O
    Hum Reprod; 2015 Dec; 30(12):2912-25. PubMed ID: 26466909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapamycin preserves the primordial follicle pool during cisplatin treatment in vitro and in vivo.
    Xie Y; Li S; Zhou L; Lin H; Jiao X; Qiu Q; Liang Y; Zhang Q
    Mol Reprod Dev; 2020 Apr; 87(4):442-453. PubMed ID: 32112509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cisplatin- and cyclophosphamide-induced primordial follicle depletion is caused by direct damage to oocytes.
    Nguyen QN; Zerafa N; Liew SH; Findlay JK; Hickey M; Hutt KJ
    Mol Hum Reprod; 2019 Aug; 25(8):433-444. PubMed ID: 30953068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can dicoumarol be used as a gonad-safe anticancer agent: an in vitro and in vivo experimental study.
    Aras D; Cinar O; Cakar Z; Ozkavukcu S; Can A
    Mol Hum Reprod; 2016 Jan; 22(1):57-67. PubMed ID: 26612783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted anti-apoptosis activity for ovarian protection against chemotherapy-induced ovarian gonadotoxicity.
    Tan SJ; Lee LJ; Tzeng CR; Wang CW; Hsu MI; Chen CH
    Reprod Biomed Online; 2014 Nov; 29(5):612-20. PubMed ID: 25246113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of gonadotropin-releasing hormone agonist on the effect of chemotherapy upon ovarian cancer and the prevention of chemotherapy-induced ovarian damage: an experimental study with nu/nu athymic mice.
    Lin QY; Wang YF; Weng HN; Sheng XJ; Jiang QP; Yang ZY
    J Zhejiang Univ Sci B; 2012 Nov; 13(11):894-903. PubMed ID: 23125082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment with anticancer agents induces dysregulation of specific Wnt signaling pathways in human ovarian luteinized granulosa cells in vitro.
    Sanchez AM; Giorgione V; Viganò P; Papaleo E; Candiani M; Mangili G; Panina-Bordignon P
    Toxicol Sci; 2013 Nov; 136(1):183-92. PubMed ID: 23956100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alleviation of endoplasmic reticulum stress protects against cisplatin-induced ovarian damage.
    Wu Y; Ma C; Zhao H; Zhou Y; Chen Z; Wang L
    Reprod Biol Endocrinol; 2018 Sep; 16(1):85. PubMed ID: 30176887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The magnetic resonance imaging contrast agent mangafodipir exerts antitumor activity via a previously described superoxide dismutase mimetic activity.
    Karlsson JO; Brurok H; Towart R; Jynge P
    Cancer Res; 2006 Jan; 66(1):598; author reply 598. PubMed ID: 16397277
    [No Abstract]   [Full Text] [Related]  

  • 15. Protective effect of proanthocyanidin against oxidative ovarian damage induced by 3-nitropropionic acid in mice.
    Zhang JQ; Xing BS; Zhu CC; Shen M; Yu FX; Liu HL
    Genet Mol Res; 2015 Mar; 14(1):2484-94. PubMed ID: 25867394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective properties of glycogen synthase kinase-3 inhibition against doxorubicin-induced oxidative damage to mouse ovarian reserve.
    Niringiyumukiza JD; Cai H; Chen L; Li Y; Wang L; Zhang M; Xu X; Xiang W
    Biomed Pharmacother; 2019 Aug; 116():108963. PubMed ID: 31125824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic effect of melatonin and ghrelin in preventing cisplatin-induced ovarian damage via regulation of FOXO3a phosphorylation and binding to the p27
    Jang H; Na Y; Hong K; Lee S; Moon S; Cho M; Park M; Lee OH; Chang EM; Lee DR; Ko JJ; Lee WS; Choi Y
    J Pineal Res; 2017 Oct; 63(3):. PubMed ID: 28658519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fodipir and its dephosphorylated derivative dipyridoxyl ethyldiamine are involved in mangafodipir-mediated cytoprotection against 7β-hydroxycholesterol-induced cell death.
    Laskar A; Andersson RG; Li W
    Pharmacology; 2013; 92(3-4):182-6. PubMed ID: 24080534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Melatonin prevents cisplatin-induced primordial follicle loss via suppression of PTEN/AKT/FOXO3a pathway activation in the mouse ovary.
    Jang H; Lee OH; Lee Y; Yoon H; Chang EM; Park M; Lee JW; Hong K; Kim JO; Kim NK; Ko JJ; Lee DR; Yoon TK; Lee WS; Choi Y
    J Pineal Res; 2016 Apr; 60(3):336-47. PubMed ID: 26882203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel molecular mechanism for anticancer drug-induced ovarian failure: Irinotecan HCl, an anticancer topoisomerase I inhibitor, induces specific FasL expression in granulosa cells of large ovarian follicles to enhance follicular apoptosis.
    Utsunomiya T; Tanaka T; Utsunomiya H; Umesaki N
    Int J Oncol; 2008 May; 32(5):991-1000. PubMed ID: 18425325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.